The nasal NK/T cell lymphoma is a rare, extranodal non-Hodgkin lymphoma in western civilizations, which has poor prognosis. The Epstein–Barr virus can be detected in tumor cells in nearly all cases. There are no definite treatment guidelines in our days. There is no significant difference in survival between radiotherapy and chemotherapy according to Asian studies. In this case study we show our diagnostic procedures, our treatment options and we present the summary of this illness based on the data found in the literature.
SYNERGISTIC ANTICANCER EFFECT OF COMBINED CHIDAMIDE AND ETOPOSIDE TREATMENT AGAINST NK/T CELL LYMPHOMA